These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 30340518)

  • 1. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
    Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
    Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
    Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
    Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
    Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
    Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
    J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.
    Aichholzer F; Klafki HW; Ogorek I; Vogelgsang J; Wiltfang J; Scherbaum N; Weggen S; Wirths O
    Alzheimers Res Ther; 2021 May; 13(1):94. PubMed ID: 33947460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM1 facilitates microglial phagocytosis of amyloid beta.
    Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
    Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
    Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
    Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
    J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
    Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
    Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
    Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
    Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
    Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
    Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease.
    Kamphuis W; Kooijman L; Schetters S; Orre M; Hol EM
    Biochim Biophys Acta; 2016 Oct; 1862(10):1847-60. PubMed ID: 27425031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.